MANAge-DM: Nurse Case Management for Diabetes in Formerly Incarcerated Black Men

This study, called MANAGe-DM, is testing a new type of nurse support for formerly incarcerated Black men with type 2 diabetes (a condition where your body doesn't use sugar properly, leading to high blood sugar). All participants will receive monthly diabetes education mailings. Some will also get extra support from a nurse case manager through two phone calls each month. The study aims to see if this extra support improves blood sugar control (measured by Hemoglobin A1C, a test that shows your average blood sugar over 2-3 months) and other health outcomes after 6 months. You might be able to join if you are a Black or African American man, at least 18 years old, have been incarcerated, have type 2 diabetes with an HbA1c of 8% or higher, and can speak English. The study is currently unclear on its recruitment status and plans to enroll 100 participants.

Study design
This is a randomized control trial involving 100 participants. Participants will be assigned by chance to either receive monthly educational mailings or the mailings plus nurse case management.
What's involved
Participants will receive monthly diabetes education mailings. If assigned to the nurse case management group, you will also have two phone calls with a nurse each month for the study period.
Compensation
Not stated in the trial record.
Follow-up
Your Hemoglobin A1C will be measured at 6 months after you are assigned to a group.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06031428

MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men

Recruiting
PHASE2Ages 18+InterventionalTreatment
Medical College of Wisconsin
~100 participants
Updated 2025-09-17 on ClinicalTrials.gov
What's tested:MANAGe-DM - novel nurse case managementMonthly Educational Mailing

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hemoglobin A1C
Measured over 6 months post-randomization
Diabetes Mellitus, Type 2
1 sites across 1 states
Wisconsin1
  • Laura Hawks, MD · PRINCIPAL_INVESTIGATOR · Medical College of Wisconsin

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age ≥18 years
identify as Black or African American
identify as male
formerly incarcerated in a state or federal prison system or county jail
clinical diagnosis of type 2 diabetes with HbA1c ≥8% at the screening visit
able to communicate in English.

Exclusion

mental confusion on screening interview suggesting significant dementia
current participation in other diabetes clinical trials
active psychosis or acute mental disorder
life expectancy \<12 months
awaiting arraignment, trial, sentencing in the criminal legal system
on active surveillance by the criminal legal system, meaning on house arrest or subject to electronic monitoring
  • Hemoglobin A1C6 months post-randomization

    Venous draw will be use to obtain HbA1C